Evolent Health (EVH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
Annual meeting scheduled for June 4, 2026, with voting open until June 3, 2026, at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by May 21, 2026.
Voting can be done online, by mail, or in person at the virtual meeting.
Voting matters and shareholder proposals
Election of ten directors, each recommended by the board for approval.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote to approve executive compensation for 2025.
Approval of amendment to the 2015 Omnibus Incentive Compensation Plan.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends all ten director nominees for election at the annual meeting.
Latest events from Evolent Health
- Q1 revenue up 2.6% to $496.2M, net loss narrows, and new contracts drive future growth.EVH
Q1 20267 May 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.EVH
Proxy filing24 Apr 2026 - 2026 guidance projects 30–33% revenue growth and margin expansion, led by new contracts.EVH
Q4 202513 Apr 2026 - Strong pipeline, conservative guidance, and focus on profitability drive growth outlook.EVH
Oppenheimer 36th Annual Healthcare MedTech & Services Conference17 Mar 2026 - AI-driven specialty care and recent acquisitions fuel growth toward a $300M EBITDA target.EVH
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Q2 revenue up 37.9% to $647.1M, net loss narrows, new contracts and Machinify acquisition completed.EVH
Q2 20241 Feb 2026 - AI acquisition and strong growth position the firm for major efficiency and margin gains.EVH
William Blair 44th Annual Growth Stock Conference31 Jan 2026 - Revenue up 21.6% but profitability pressured by medical costs; record new contracts signed.EVH
Q3 202415 Jan 2026 - Oncology cost trends are surging, prompting urgent contract and operational adjustments.EVH
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026